Adenia Partners to Acquire Majority Stake in Parkville Pharmaceuticals
Adenia Partners, a private equity firm focused on growth opportunities across Africa, announced the signing of a definitive agreement to acquire a majority stake in Parkville Pharmaceuticals from Admaius Capital Partners, one of Africa’s leading private equity firms, alongside participation from Dr. Sherif Bassiouny, Chairman of Parkville, and Dr. Mahmoud Farag, the company’s Chief Executive Officer.
The transaction remains subject to customary closing conditions and required regulatory approvals. Financial terms of the deal were not disclosed.
Parkville Pharmaceuticals is one of Egypt’s leading healthcare and pharmaceutical companies, with operations spanning pharmaceuticals, cosmeceuticals, and nutraceuticals. Founded in 2008 and headquartered in Cairo, the company focuses on the development, manufacturing, and distribution of innovative products, including skincare and haircare solutions, personal care products, deodorants, as well as therapeutic medicines.
In recent years, Parkville has recorded strong growth driven by continued investment in research and development, enhanced quality standards, and an expanded product portfolio. This growth has strengthened its position as a key local player in Egypt’s fast-growing cosmeceuticals market, outperforming several local and international brands.
Through its partnership with Parkville’s founders and management team, Adenia Partners aims to support the company’s next phase of growth by expanding its product offerings, accelerating digital transformation, strengthening e-commerce channels, and entering new regional markets.
This investment aligns with Adenia’s strategy of building African businesses capable of delivering long-term, sustainable growth.